KeyCorp Risk Chief Exited at $22.74; Stock at $21.79
KeyCorp's Chief Risk Officer sold $568,500 in company stock on July 22 — one day after the bank disclosed a fourth consecutive earnings beat. The stock has since fallen to $21.79, leaving the CRO's $2
KeyCorp Risk Chief Exited at $22.74; Stock at $21.79
NEW YORK, September 8 —
KeyCorp (KEY) has beaten Wall Street's EPS estimate for four consecutive quarters, yet the executive whose job is to price the bank's own risk chose the day after Q2 results were filed to sell $568,500 in stock at $22.74, a price the shares have not seen since. The gap between what insiders were willing to accept and what the market now offers is a question the beat streak alone cannot answer.
- Q2 2026 EPS of $0.44 beat consensus by 4.7%, per KeyCorp's July 21 8-K.
- CRO Mohit Ramani sold 25,000 shares at $22.74 on July 22; shares trade at $21.79 as of September 8.
- Scotiabank disposed of 898,422 shares across four transactions from June 16 to July 7, all above today's price.
Four Beats, One Sale
KeyCorp operates KeyBank National Association, offering retail and commercial banking, deposits, mortgages, student loan refinancing, and credit cards on the consumer side; equipment financing, syndicated lending, debt underwriting, and M&A advisory on the commercial side. The four-quarter beat streak is real: $0.41 against in Q3 2025, $0.41 against in Q4, $0.44 against in Q1 2026, and $0.44 against in Q2, a consistent pattern of modest but compounding outperformance against a $7.37 billion trailing revenue base growing at 10.1% year-over-year. Mohit Ramani's Form 4 arrived one day after the Q2 filing. A chief risk officer timing a sale to the first window after earnings is not unusual; selling below any subsequent recovery would be irrelevant. That recovery has not come.
The Selling Pattern
Ramani's $568,500 open-market sale was the only insider transaction in the 90-day period, no KeyCorp insider made an open-market purchase. Scotiabank, a director and 10% holder, made four non-market dispositions totaling 898,422 shares between June 16 and July 7, at prices ranging from $22.13 to $23.18. Every Scotiabank exit price sits above the current $21.79. The bank also filed an S-3ASR automatic shelf registration and a 424B5 prospectus supplement in early June, before the Scotiabank dispositions began. Shelf registrations do not signal imminent dilution, but the sequence, shelf, then large-block dispositions, then CRO sale, is worth holding against any forward guidance.
| Ticker | Mkt cap | Fwd P/E | 52-wk |
|---|---|---|---|
| KEY | $23.3B | 10.2x | +16.1% |
| HBAN | $33.9B | 8.9x | -3.5% |
| FITB | $49.4B | 11.0x | +20.8% |
| RF | $25.6B | 10.6x | +13.4% |
| PNC | $96.9B | 11.4x | +22.5% |
| MTB | $34.4B | 11.3x | +20.0% |
What to Watch
The analyst consensus price target of $26.02 against a current price of that level implies roughly 19% upside, and a forward P/E of 10.2x is undemanding for a bank posting consistent beats. KeyCorp carries $15.35 billion in total debt against $2.84 billion in cash and $1.31 billion in trailing operating cash flow, a balance sheet that leaves limited room for credit deterioration. The number to watch next quarter is the CRO's own domain: credit quality metrics in Q3 2026. If non-performing assets rise while the beat streak continues, the insider exit reads differently than it does today. Run the free KeyCorp deep-dive →
Current fundamentals, valuation and filing history for KeyCorp (KEY) are tracked on its Basis Report page.
Basis Report is independent research for informational purposes. It is not investment advice and not a recommendation to buy or sell any security.
KeyCorp's Chief Risk Officer sold $568,500 in company stock on July 22 — one day after the bank disclosed a fourth consecutive earnings beat. The stock has since fallen to $21.79, leaving the CRO's $22.74 exit price as the high-water mark the shares have not reclaimed.
Sources & Filings